Rx-360 Announces Approval as a Pilot Center of Excellence for the APEC Regulatory Harmonization Steering Committee

September 25, 2024 11:09 PM AEST | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

PHILADELPHIA, Sept. 25, 2024 /PRNewswire/ -- Rx-360® is pleased to announce that it has been accepted as a Pilot Center of Excellence (CoE) for the APEC Regulatory Harmonization Steering Committee. The pilot will be focused on the Global Medical Product Supply Chain Integrity Priority Work Area Roadmap. As an international non-profit, with a mission based on pharmaceutical supply chain integrity, material quality, and patient safety, Rx-360® will be able to bring its 15 years of experience to help drive the mission of Asia Pacific Economic Cooperation (APEC).

Jim Fries, CEO of Rx-360 commented, "This is a tremendous honor for our consortium to be able serve the APEC mission around medical product safety. We look forward to working with the other Centers of Excellence, US Pharmacopeia, and Taylor's University in Malaysia, to enhance the already great educational offerings available to the industry."

Economies are adversely impacted by the international movement of substandard and falsified medical products. As the medical products industry has become more globalized and specialized, APEC economies are faced with many challenges in keeping citizens healthy, while ensuring that access to legitimate products is not disrupted. To address this issue, the Roadmap for Global Medical Product Quality and Supply Chain Security project (Roadmap) was developed. The Roadmap was a multi-year effort commissioned by APEC with oversight by the Regulatory Harmonization Steering Committee (RHSC). It became a priority work area (PWA) in APEC, bringing together regulators, industry members, academics, and other stakeholders from across the APEC economies, and EU, Africa, and other parts of South America. This work culminated in the development of the Supply Chain Security Toolkit (Toolkit) in 2017. The Toolkit contains training materials intended to educate regulators, industry members, and others on a particular part of the supply chain, including its best practices, guidance documents, etc. The Toolkit includes ten (10) work streams, covering the entire supply chain and life cycle of medical products. This Toolkit will be the focus of educational workshops and relevant training designed and offered by Rx-360 as part of the pilot CoE.

About Rx-360:
Rx-360, an international pharmaceutical supply chain consortium, was formed in 2009 to support an industry-wide commitment to ensuring patient safety by enhancing quality and authenticity throughout the supply chain. The organization's mission is to protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of materials within the supply chain. To learn more about Rx-360, please visit http://www.Rx-360.org or email [email protected].

About APEC Regulatory Harmonization Steering Committee:
The Regulatory Harmonization Steering Committee (RHSC) was formed in June 2009 under the auspices of APEC to promote a strategic approach to regulatory harmonization by undertaking activities of greatest value to regulatory authorities and regulated industries. It is a network of regulatory experts from regulatory agencies in APEC economies, industry and academia with the vision of achieving greater regulatory convergence within the APEC economies by 2020. The RHSC does not seek to develop new guidances but is designed to play a complementary role to other regional international regulatory initiatives.

Contact: James Fries, [email protected]


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.